Overview
Key Metrics Quarterly
P&L
Balance Sheet
Cash Flows
Ratios
Shareholding
Documents
About
Bharat Parenterals Limited engages in the research, development, manufacturing, marketing, sourcing, and distribution of pharmaceutical products in India and internationally. The company provides antibiotics, cardiovascular and central nervous system, antifungal, antimalarial, gastrointestinal tract/alimentary systems, analgesics, anaesthetics, quinolones, erectile dysfunction medicines, nutritional supplements, steroids and hormones, and other drugs. It also engages in manufacturing of general products in capsules, tablets, ointment and creams, injections, oral liquids, and powder sachets forms; and beta lactum and cephalosporin products in capsules, tablets, dry syrup, and powder for injection forms. In addition, it offers eye drops. Bharat Parenterals Limited was incorporated in 1992 and is based in Vadodara, India.
Key Metrics
as of Sep 2026
Market Cap 1,057 Cr
P/E β
Div Yield 0.07 %
Book Value βΉ468.00
52w High βΉ1,649.00
52w Low βΉ880.00
Face Value βΉ10.00
Quarterly Results
Rs. Crores Β· hover row for definition
Metric
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Jun 2023
Sales
55.50
56.54
41.41
41.70
94.37
80.28
67.34
64.45
92.06
65.64
58.80
59.81
69.91
Expenses
48.67
56.51
37.94
39.36
79.11
75.68
58.99
58.79
77.07
61.91
52.02
53.38
58.42
Operating Profit
6.83
0.03
3.47
2.34
15.26
4.60
8.35
5.66
14.99
3.73
6.78
6.43
11.49
OPM %
12.31
0.05
8.38
5.61
16.17
5.73
12.40
8.78
16.28
5.68
11.53
10.75
16.44
Other Income
1.05
4.44
2.28
4.21
1.62
2.26
3.79
4.60
3.90
3.24
2.40
3.46
2.86
Depreciation
2.26
2.04
2.10
2.17
2.06
1.82
1.86
1.75
1.61
1.61
1.67
1.61
1.51
Interest
0.69
0.51
0.55
0.96
1.42
1.48
1.41
0.88
1.02
1.09
0.61
0.61
0.88
Profit before tax
4.93
1.92
3.10
3.42
13.40
3.56
8.87
7.63
16.26
4.27
6.90
7.67
11.96
Tax %
25.96
28.65
38.06
20.18
25.37
35.96
26.61
28.05
25.09
28.10
26.52
27.51
25.67
Net Profit
3.66
1.38
1.92
2.73
10.00
2.28
6.50
5.49
12.18
3.07
5.07
5.56
8.89
EPS in Rs
5.31
2.00
2.79
3.96
14.51
3.31
9.43
8.41
18.67
5.28
8.71
9.55
15.39
Profit & Loss
Annual Β· Rs. Crores
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Sales
234.00 304.00 258.00 218.00 212.00 204.00 226.00 220.00 136.00 111.00 125.00 119.00
Expenses
213.00 269.00 225.00 196.00 183.00 179.00 196.00 189.00 123.00 104.00 114.00 108.00
Operating Profit
21.00 35.00 33.00 22.00 29.00 25.00 30.00 30.00 13.00 7.00 10.00 11.00
OPM %
9.00 11.00 13.00 10.00 14.00 12.00 13.00 14.00 10.00 6.00 8.00 9.00
Other Income
13.00 14.00 8.00 19.00 7.00 9.00 11.00 13.00 7.00 8.00 5.00 4.00
Interest
3.00 5.00 4.00 3.00 1.00 1.00 1.00 1.00 1.00 1.00 1.00 2.00
Depreciation
8.00 7.00 6.00 6.00 7.00 6.00 6.00 6.00 6.00 6.00 4.00 4.00
Profit before tax
22.00 36.00 31.00 32.00 28.00 27.00 35.00 36.00 14.00 8.00 9.00 9.00
Tax %
27.00 27.00 27.00 24.00 25.00 25.00 25.00 37.00 27.00 7.00 31.00 15.00
Net Profit
16.00 26.00 23.00 24.00 21.00 20.00 26.00 23.00 10.00 7.00 6.00 7.00
EPS in Rs
23.24 38.38 38.82 42.15 36.89 35.27 45.90 39.39 17.63 12.88 11.26 12.98
Dividend Payout %
4.00 3.00 3.00 2.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Balance Sheet
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Equity Capital
7.00 7.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00 6.00
Reserves
395.00 380.00 208.00 185.00 160.00 138.00 117.00 91.00 69.00 58.00 51.00 44.00
Borrowings
20.00 65.00 83.00 46.00 15.00 12.00 1.00 5.00 9.00 6.00 19.00 16.00
Other Liabilities
98.00 98.00 91.00 71.00 37.00 40.00 68.00 60.00 50.00 40.00 44.00 50.00
Total Liabilities
520.00 549.00 387.00 308.00 218.00 196.00 192.00 161.00 133.00 111.00 120.00 116.00
Fixed Assets
51.00 46.00 39.00 36.00 41.00 45.00 33.00 35.00 34.00 31.00 35.00 29.00
CWIP
6.00 5.00 0.00 0.00 1.00 0.00 12.00 1.00 0.00 0.00 0.00 0.00
Investments
195.00 168.00 49.00 38.00 16.00 42.00 0.00 2.00 1.00 1.00 0.00 0.00
Other Assets
269.00 330.00 299.00 233.00 160.00 110.00 147.00 123.00 99.00 79.00 85.00 87.00
Total Assets
520.00 549.00 387.00 308.00 218.00 196.00 192.00 161.00 133.00 111.00 120.00 116.00
Cash Flows
Annual Β· Rs. Crores β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2015
Cash from Operating Activity
45.00 19.00 0.00 -12.00 -22.00 30.00 14.00 20.00 6.00 -2.00 0.00
Cash from Investing Activity
4.00 -90.00 -38.00 -14.00 22.00 -46.00 -13.00 -9.00 -8.00 -2.00 0.00
Cash from Financing Activity
-49.00 69.00 34.00 29.00 2.00 8.00 -3.00 -4.00 4.00 -8.00 0.00
Net Cash Flow
0.00 -1.00 -5.00 3.00 2.00 -8.00 -1.00 7.00 2.00 -11.00 0.00
Free Cash Flow
30.00 -1.00 -10.00 -7.00 -27.00 24.00 0.00 11.00 -2.00 -4.00 0.00
CFO/OP %
250.00 85.00 28.00 -13.00 -56.00 145.00 81.00 102.00 67.00 -4.00 0.00
Ratios
Annual Β· Days / % β latest first
Metric
Mar 2026 Mar 2025 Mar 2024 Mar 2023 Mar 2022 Mar 2021 Mar 2020 Mar 2019 Mar 2018 Mar 2017 Mar 2016 Mar 2015
Debtor Days
188.00 198.00 198.00 188.00 126.00 122.00 132.00 109.00 158.00 144.00 129.00 179.00
Inventory Days
131.00 90.00 125.00 100.00 56.00 61.00 69.00 55.00 60.00 69.00 62.00 55.00
Days Payable
97.00 121.00 121.00 127.00 60.00 71.00 106.00 82.00 110.00 167.00 171.00 188.00
Cash Conversion Cycle
222.00 167.00 202.00 161.00 122.00 111.00 95.00 82.00 108.00 46.00 20.00 47.00
Working Capital Days
172.00 97.00 68.00 98.00 150.00 111.00 97.00 78.00 82.00 65.00 8.00 58.00
ROCE %
6.00 11.00 13.00 14.00 18.00 20.00 32.00 40.00 19.00 12.00 15.00 17.00
Shareholding Pattern
% holding β latest first
Quarterly
Yearly
Holder
Jun 2026
Mar 2026
Dec 2025
Sep 2025
Jun 2025
Mar 2025
Dec 2024
Sep 2024
Jun 2024
Mar 2024
Dec 2023
Sep 2023
Promoters
67.20
67.17
67.19
67.19
67.19
67.20
67.20
65.35
73.27
73.27
73.84
73.84
FIIs
0.11
0.11
0.11
0.11
0.11
0.11
0.11
0.08
0.00
0.00
0.00
0.00
DIIs
1.38
1.07
0.54
0.54
0.54
0.54
0.54
0.57
0.01
0.01
0.01
0.01
Public
31.31
31.65
32.17
32.16
32.16
32.15
32.16
33.98
26.72
26.72
26.15
26.15
No. of Shareholders
3,059
3,095
3,172
3,205
3,231
3,177
3,116
2,748
2,708
2,497
2,397
2,481
Corporate Actions
3 records
Back to all stocks